- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/00 - Drugs for dermatological disorders
Patent holdings for IPC class A61P 17/00
Total number of patents in this class: 8834
10-year publication summary
|
368
|
356
|
326
|
543
|
575
|
775
|
726
|
787
|
722
|
196
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shiseido Company, Ltd. | 3761 |
112 |
| Galderma Research & Development | 440 |
99 |
| AMOREPACIFIC Corporation | 2606 |
60 |
| Novartis AG | 11238 |
50 |
| Osaka University | 3143 |
49 |
| Sol-gel Technologies Ltd. | 170 |
42 |
| Incyte Corporation | 918 |
41 |
| Daiichi Sankyo Company, Limited | 1829 |
40 |
| ELC Management LLC | 1027 |
40 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
40 |
| The Regents of the University of California | 18943 |
39 |
| Boehringer Ingelheim International GmbH | 4629 |
38 |
| Pierre Fabre Dermo-Cosmetique | 380 |
38 |
| Galderma S.A. | 174 |
37 |
| L' Oréal | 5103 |
37 |
| Allergan, Inc. | 2600 |
35 |
| Takeda Pharmaceutical Company Limited | 2961 |
35 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
35 |
| Kao Corporation | 4843 |
34 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
34 |
| Other owners | 7899 |